| Bioactivity | SIRT2-IN-8 is a potent SIRT2 inhibitor. SIRT2-IN-8 can be used for Huntington’s and Parkinson’s diseases research[1]. |
| Name | SIRT2-IN-8 |
| CAS | 115687-05-3 |
| Formula | C20H17ClN4O3 |
| Molar Mass | 396.83 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Bodner RA, Outeiro TF, Altmann S, et al. Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci U S A. 2006;103(11):4246-4251. |
SIRT2-IN-8
CAS: 115687-05-3 F: C20H17ClN4O3 W: 396.83
SIRT2-IN-8 is a potent SIRT2 inhibitor. SIRT2-IN-8 can be used for Huntington’s and Parkinson’s diseases research.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.